MERIDIA (Sibutramine) drug information from MPR
Links shared publicly online about this topic.
- 1,292total visits
MERIDIA (Sibutramine) drug information from MPR
empr.com —
MERIDIA (Sibutramine) drug information for Obesity from MPR including side effects, drug interactions, dosing, contraindications and precautions.
View full resource at empr.com
Most Recently Shared on March 24, 2010 at 5:03 am By:
MPR News: MERIDIA: Contraindications: cardiovascular risks added. http://bit.ly/9toPEt
Weight loss drug pulled from market – The Chart - CNN.com Blogs
pagingdrgupta.blogs.cnn.com — “Abbott Laboratories has agreed to take its obesity drug Meridia (sibutramine) off the market, the U.S. Food and Drug Administration announced Friday. The company voluntarily withdrew the drug because clinical trial studies showed there was an increased risk of heart attacks and strokes in people ...” View full resource at pagingdrgupta.blogs.cnn.com
Most Recently Shared on October 8, 2010 at 4:41 pm By:
James Beckerman, MD Internist, Cardiologist, Physician, and Doctor
Glad I was able to add this important information before we go to publication! http://bit.ly/d1vJMZ #sibutramine
Advertisement
